One of the key morphological changes associated with the nerve growth factor (NGF)-induced differentiation of rat adrenal pheochromocytoma (PC-12) cells is the growth of axon-like processes called neurites. A growing body of evidence suggests that this process may be dependent upon plasmin, a serine protease generated from plasminogen (Plg) by either urokinase Plg activator (u-PA) or tissue Plg activator (t-PA). Prior work in our laboratory has identified annexin II (Ann-II) as a coreceptor for Plg and t-PA that promotes and localizes plasmin generation near the cell surface. In the present study, we report a 3-9-fold increase in Ann-II protein and message levels in NGF-treated PC-12 cells. Message stability and nuclear run-on assays suggest that this induction occurs at the level of gene transcription. Neurite outgrowth assays on and within a three-dimensional matrix demonstrate the inhibition of NGF-induced PC-12 cell differentiation by polyclonal and monoclonal antibodies directed against Ann-II as well as by the overexpression of antisense Ann-II mRNA. Neuritogenesis is also impaired by ␣ 2 -plasmin inhibitor, antibodies directed against t-PA and u-PA, and ⑀-aminocaproic acid, a lysine analog that inhibits Plg activation and the binding of Plg to Ann-II. Plasmin generation assays reveal a 2-fold increase in plasmin production on NGF-treated PC-12 cells, which can be blocked by a polyclonal antibody directed against the tail region of Ann-II. From these data, we conclude that Ann-II is transcriptionally up-regulated by NGF and that Ann-II-mediated plasmin generation may play an important role during neurite development in the differentiating PC-12 cell.
Nerve growth factor (NGF), 1 a member of the neurotrophin growth factor family, plays a critical role in the differentiation and long term survival of peripheral sympathetic and neural crest-derived sensory neurons. The binding of NGF to a receptor tyrosine kinase encoded by the trkA proto-oncogene initiates a signal transduction cascade that halts cell proliferation and induces a new program of gene expression and protein synthesis (1) . Gene targeting studies have demonstrated the importance of NGF to neuronal survival and function; mice completely deficient in either NGF (2) or TrkA (3) do not survive to adulthood and display neuronal atrophy in their dorsal root and sympathetic ganglia. The disruption of even one NGF gene allele gives rise to significant memory and learning deficits that can be minimized by the administration of exogenous NGF (4) . The addition of NGF to rat adrenal pheochromocytoma (PC-12) cells leads to cell cycle arrest and differentiation into cells resembling sympathetic neurons. Phenotypic changes associated with NGF-induced differentiation include the biosynthesis of neurotransmitters, the acquisition of electrical excitability, and the growth of axon-like extensions called neurites through a process known as neuritogenesis (5) . Neuritogenesis is a complex phenomenon that involves multiple interactions between the growing neurite and the extracellular matrix. The extent and direction of neurite outgrowth is largely influenced by proteolytic activity, which regulates the neurite's adhesive properties and carves a channel in the extracellular matrix through which the neurite can grow (6) . There is abundant evidence that proteolytic activity near the neurite-extracellular matrix interface may be mediated in part by the serine proteases, urokinase plasminogen activator (u-PA) and tissue plasminogen activator (t-PA) (6 -9) . In the vascular fibrinolytic system, u-PA and t-PA help to maintain blood fluidity by converting plasminogen (Plg) into plasmin, a serine protease whose major physiological role is the degradation of fibrin-rich intravascular thrombi (10) . Within the developing nervous system, the expression of t-PA and u-PA is restricted to migrating tissues such as cerebellar granule cells (11) and neural crest cells (6) and to regions of axonal growth such as the floor plate of the spinal cord (6, 8) . Plg activators are also found on the neurites of differentiating rat sympathetic neurons (12) , neuroblastoma cells (7) , and PC-12 cells (13) .
The high level of Plg activators observed in neuronal tissues suggests that, in this environment, they may be involved in processes other than the degradation of fibrin. Indeed, the overexpression of t-PA in cultured PC-12 cells results in enhanced neurite regeneration that can be blocked with anti-t-PA antibodies (9) . The up-regulation of t-PA expression in the rat brain has been observed in response to long term potentiation, chemically induced seizures, and an electrically induced form of epilepsy called kindling (14) . Increased levels of t-PA mes-sage and protein are also observed in the cerebellar Purkinje neurons of rats that have been trained to perform a complex task (15) . Moreover, it has been shown that inhibitors of t-PA can block chemically induced long term potentiation and axonal elongation in the hippocampus, whereas the addition of exogenous t-PA has the opposite effect (16) . Together, these studies suggest that the induction of t-PA expression may play a role in neuronal plasticity and synaptic remodeling within the hippocampus and cerebellum during memory formation and motor learning.
In previous studies using human umbilical vein endothelial cells (HUVEC), we have identified annexin II (Ann-II) as an extracellular co-receptor for Plg and t-PA that enhances t-PAdependent Plg activation nearly 60-fold in a purified system (17, 18) . Ann-II is a 36-kDa member of the annexin gene family, a group of ϳ20 Ca 2ϩ -and phospholipid-binding proteins that consist of a conserved carboxyl-terminal core domain and a variable amino-terminal tail domain (19) . Ann-II is expressed on the surface of smooth muscle cells, glioma cells (20) , endothelial cells (17, 20) , and acute promyelocytic leukemia cells (21) . Its expression is developmentally regulated in the chicken lens (22) , the rat cerebellum (23) , and the murine central nervous system (24) . One of the unique features of Ann-II is its ability to form a heterotetramer with p11, a M r 11,000 member of the S100 calcium-binding protein family. The p11 subunit binds to the amino-terminal tail region of the Ann-II monomer and is thought to regulate the heterotetramer's affinity for phospholipids (25) . Recent reports suggest that the heterotetramer or even p11 itself may also stimulate t-PA-dependent plasmin generation (26) . Previous work done in our laboratory suggests that Ann-II may act as a scaffold for the generation of plasmin near the cell surface by forming a membrane-bound ternary complex with Plg and t-PA. We have shown that Plg binding to Ann-II is inhibited by the lysine analog ⑀-aminocaproic acid (⑀ACA) (18) and requires a carboxyl-terminal lysine residue in the core domain (17) . The binding of t-PA to Ann-II involves the N-terminal tail domain and is inhibited by homocysteine, a proatherothrombotic amino acid that accumulates as a result of inborn errors of metabolism and certain nutritional deficiencies (27) .
There is evidence in the literature that Ann-II may be involved in neuronal cell differentiation and development. In the developing murine nervous system, Ann-II is detected in dorsal root ganglion cells, sensory ganglion cell axons, and midline structures throughout the developing spinal cord, brain stem, and mesencephalon (24) . In PC-12 cells, NGF-induced differentiation is accompanied by increased Ann-II expression at the message and protein levels (28, 29) . Moreover, the overexpression of p11 results in the constitutive outgrowth of neurites in PC-12 cells (30) . In the present study, we examine the relationship between the expression of cell surface Ann-II, Ann-IImediated plasminogen activation, and neuritogenesis during NGF-induced PC-12 cell differentiation.
EXPERIMENTAL PROCEDURES
Reagents and Materials-Cell culture media, supplements, and sera were purchased from Life Technologies. Mouse 2.5 S NGF was supplied by Harlan Bioproducts, and recombinant human epidermal growth factor (EGF) was purchased from R & D Systems. Alkaline phosphatase and fluorescein isothiocyanate-conjugated goat anti-mouse and goat anti-rabbit IgG were purchased from ICN Biomedicals. A rabbit polyclonal antibody directed against human Ann-II was prepared as described (18) , and a mouse monoclonal anti-Ann-II antibody was purchased from Transduction Laboratories. A polyclonal antibody against an Ann-II N-terminal peptide (MSTVHEILCKLSLEGD) was raised in rabbit by Covance Research Products and purified with an IgG purification kit from Pierce. Glu-plasminogen, ␣ 2 -plasmin inhibitor, and inhibitory antibodies against u-PA and t-PA were purchased from American Diagnostica. Human tenascin-C was supplied by Chemicon International. Recombinant human t-PA was generously provided by Genentech and the fluorogenic plasmin substrate AFC-81 (D-Val-LeuLys-7-amino-4-trifluoromethylcoumarin) was obtained from Enzyme Systems Products. DNA-modifying enzymes were obtained from Roche Molecular Biochemicals or New England Biolabs. DNA primers were synthesized by National Biosciences or Genosys. PerkinElmer Life Sciences supplied 32 P-labeled nucleotides. All other chemicals were purchased from Sigma.
Cell Culture-HUVEC were propagated as previously described (31) . The rat pheochromocytoma (PC-12) cell line (5), a gift from Dr. Barbara Hempstead (Weill Medical College of Cornell University), was propagated in antibiotic-free high glucose Dulbecco's modified Eagle's medium supplemented with 5% heat-inactivated calf serum, 10% heatinactivated horse serum, and 2 mM L-glutamine. PC-12 cells expressing a mutant form of p21 ras (N17) (32) were generously provided by Dr. Harry Lander (Weill Medical College of Cornell University) and were cultured in the same manner as wild type PC-12 cells. PC-12 cells treated with NGF were grown on plastic wells or flasks that had been precoated with rat tail collagen (Biomedical Technologies). All cultures were maintained in a humidified chamber (37°C, 5% CO 2 ).
Western Blotting of PC-12 Cell Surface Eluates and Whole Cell Lysates-PC-12 cells were treated daily for 5 days with or without 50 ng/ml NGF. EGTA cell surface eluates were prepared and assayed for the release of lactate dehydrogenase as previously described (33) . Whole cell lysates of the EGTA-eluted cells were prepared by two freeze-thaw cycles (Ϫ80°C) in ice-cold radioimmune precipitation buffer (20 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA, 10% glycerol, 1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, pH 8.0). The eluates and lysates were centrifuged (10,000 ϫ g, 10 min), assayed for protein content, and analyzed for Ann-II content by SDS-PAGE/Western blot analysis as previously described (34) . An enhanced chemiluminescence kit (Amersham Biosciences, Inc.) was used according to the manufacturer's protocol to detect p11. Western blot data were scanned and saved as digital images using Adobe Photoshop version 4.0.1 (Adobe Systems).
Indirect Immunofluorescence Microscopy-The detection of cell surface Ann-II by indirect immunofluorescence microscopy was performed as previously described (21) . PC-12 cells treated with 50 ng/ml NGF for 5 days were stained with monoclonal anti-Ann-II (1.25 g/ml) or antiAnn-VI (1.25 g/ml) and counterstained with propidium iodide.
Northern Blot Analysis-PC-12 cells were treated with or without 50 ng/ml NGF or 50 ng/ml EGF for 3 days. Total RNA was isolated from HUVEC and PC-12 cells using Trizol reagent (Life Technologies). Equal amounts of RNA were resolved on an agarose gel and transferred to Zetaprobe (Bio-Rad) membranes as previously described (35) . The membranes were hybridized to a 32 P-labeled probe in QuickHyb solution (Stratagene) and subjected to autoradiography. The autoradiograms were scanned and digitized using Adobe Photoshop and analyzed by densitometry using the Scion Image (beta 3 version) software package (Scion Corp.).
Preparation of 32 P-Labeled Probes for Northern Blots-Probes for Northern hybridization were made with a random primed labeling kit (Roche Molecular Biochemicals). The template for a 300-bp human Ann-II tail-specific cDNA probe was prepared as previously described (21) . A cDNA probe specific for human annexin I (Ann-I) was synthesized by PCR in a 100-l volume containing 200 M dNTPs, 2.5 units of Pfu polymerase (Stratagene), 50 pmol of primers, and a HUVEC -gt11 cDNA library (36) as a template. The forward primer, 5Ј-AAAGGATC-CGGCAATGGTATCAGAATT-3Ј, contained a BamHI site and bases 3-20 of the human Ann-I sequence (37), while the reverse primer, 5Ј-AAACTCGAGGTTTCCTCCACAAAGAGC-3Ј contained an XhoI site and Ann-I bases 1021-1038. The PCR consisted of five cycles of 94°C (30 s), 52°C (60 s), and 72°C (90 s), followed by 25 cycles of 94°C (30 s), 74°C (60 s), and 72°C (90 s) and concluded with a 72°C incubation (5 min). The 1035-bp PCR product was digested with BamHI and XhoI, cloned into pET 21b, and sequenced in both directions to verify its integrity. The template for a 28 S rRNA probe was generously provided by Dr. Iris Gonzales (Hahneman University, Philadelphia, PA), and an 18 S rRNA probe was purchased from Promega.
Message Stability Assays-PC-12 cells were starved in low serum Dulbecco's modified Eagle's medium (0.5% calf serum, 1% horse serum) for 48 h and treated for an additional 48 h with no growth factor or with either 50 ng/ml EGF or 50 ng/ml NGF. The culture medium was replaced with low serum Dulbecco's modified Eagle's medium containing 4 g/ml actinomycin D, and the cells were harvested after 0, 3, 6, 9, 12, and 24 h. Total RNA was purified and analyzed by Northern blot and densitometry. The relative amounts of normalized Ann-II message were plotted as a function of time, and the slope of this curve was used to calculate the interval within which half of the original message had disappeared.
Nuclear Run-on Assay-Nuclear run-on assays of untreated and NGF-treated PC-12 cells were performed as described (35) .
Stable Transfection of PC-12 Cells with Antisense (pMEP4-AS) and Sense (pMEP4-S) Annexin II Expression
Vectors-To construct pMEP4-AS, a 365-bp BglII-HindIII fragment containing bases 33-397 of the human Ann-II cDNA sequence (38) was excised from pCMV5-Ann-II (17) and subcloned in the antisense orientation into the HindIII-BamHI sites of the zinc-inducible expression vector, pMEP4 (Invitrogen). The Ann-II sense insert for pMEP4-S was amplified from pCMV5-Ann-II in a 100-l PCR. The forward primer, 5Ј-GGGCTGGCGGTACCCCAGCT-TCCTTCAAAATGTC-3Ј contained a restriction site for KpnI and Ann-II bases 34 -54, and the reverse primer, 5Ј-ATTGAGAGAGTCCT-CGTCGG-3Ј contained bases 417-436. The PCR consisted of 25 cycles of 94°C (1 min), 56°C (1 min), and 72°C (2 min) followed by a 5-min incubation at 72°C. The 403-bp PCR product was digested with KpnI and HindIII, and the resulting 367-bp fragment was cloned in the sense orientation into pMEP4. The integrity of the PCR-derived pMEP4-S insert was confirmed by DNA sequencing in both directions.
PC-12 cells were propagated in six-well plates and transfected in serum-free medium for 6 h with 24 l of LipofectAMINE plus 2 g of pMEP4-AS or pMEP4-S plasmid DNA. Following transfection, the cells were allowed to recover in complete medium for 48 h. Selection for stable transfectants was carried out for several weeks in complete medium containing 400 g/ml hygromycin B. The presence of the pMEP4 vector in these cells was verified by both PCR and Southern blot analysis.
Neurite Outgrowth Assays-PC-12 cells were propagated on a twodimensional rat tail collagen substrate in 12-well plates and treated with 50 ng/ml NGF for 2-5 days in the presence of anti-annexin antibodies or ⑀ACA. Three-dimensional matrices were prepared by diluting Matrigel reconstituted basement membrane (Collaborative Biomedical Products) 1:1 with a PC-12 cell suspension in Dulbecco's modified Eagle's medium. Fifty l of this mixture (5000 cells) was placed onto each well of a 48-well plate and allowed to gel for 30 min in a humidified chamber (37°C, 5% CO 2 ). The embedded cells were fed for 3 days with medium containing 50 ng/ml NGF plus ␣ 2 -plasmin inhibitor or specific antibodies. Morphological changes indicative of differentiation were observed using phase contrast microscopy at ϫ100 magnification. For each treatment group, the percentage of cells bearing neurites at least two cell bodies in length was enumerated in a double-blind manner by two observers.
Fluorogenic Plasmin Generation Assays-PC-12 cells were cultured upon rat tail collagen in six-well plates (Costar) in the presence or absence of 50 ng/ml NGF for 5 days. Cells were incubated for 3 h in complete medium containing preimmune rabbit IgG or polyclonal Ann-II tail peptide antibody. The cells were washed three times with IB buffer (140 mM NaCl, 4 mM KCl, 10 mM HEPES, 0.2% glucose, 1 mM MgCl 2 , 3 mM CaCl 2 ) containing 10 mM ⑀ACA and lightly fixed for 30 min at 37°C with 0.02% glutaraldehyde in IB buffer (31) . The cells were then washed five times with IB buffer and treated with 100 nM Glu-Plg for 1 h at room temperature. The plate was washed five times, and 1 ml of IB buffer containing 10 nM t-PA premixed with the fluorogenic plasmin substrate AFC-81 (D-Val-Leu-Lys-7-amino-4-trifluoromethylcoumarin; 125 M) was added to each well. Substrate hydrolysis was measured at 2-min intervals as relative fluorescence units at 400-nm excitation and 505-nm emission in a SpectraMax Gemini XS fluorescent spectrometer (Molecular Devices). Initial rates of plasmin generation were calculated using linear regression analysis of plots of relative fluorescence units versus time 2 as previously described (31) .
RESULTS

Abundant Ann-II Protein Is Detected on the Plasma Membrane of NGF-treated PC-12
Cells-In a previous study using HUVEC (33) , we were able to differentiate between cell surface and cytosolic Ann-II by eluting the cell monolayer with 10 mM EGTA, a chelator that disrupts the Ca 2ϩ -dependent binding of Ann-II to the cell surface. In the present study, we used a similar strategy to compare levels of Ann-II expression in EGTA cell surface eluates and whole cell lysates prepared from PC-12 cells treated with or without 50 ng/ml NGF for 5 days (Fig. 1A) . The EGTA cell surface eluates were tested as described under "Experimental Procedures" for the presence of lactate dehydrogenase, an enzyme that resides solely in the cytoplasm. The results of this assay revealed no evidence of reduced cellular integrity during the EGTA elution (data not shown) and provided assurance that the Ann-II detected in the eluates originated on the outer surface of the cell.
We observed low levels of Ann-II protein in either fraction prepared from untreated PC-12 cells. However, significantly increased amounts of Ann-II protein were found in both cell surface eluates and whole cell lysates prepared from the NGFtreated cells. Detectable levels of p11 were not found in the eluted fraction of either treatment group (Fig. 1B) . However, we observed a dramatic increase in p11 expression in the whole cell lysates of NGF-treated cells. These data confirmed previous reports of increased Ann-II expression in differentiating PC-12 cells (28, 29) , and they also demonstrated the abundant presence of Ann-II protein on the surface of NGF-treated PC-12 cells. These findings were corroborated by an immunohistochemical analysis (Fig. 1C) of NGF-treated PC-12 cells subjected to cell surface staining with a monoclonal anti-Ann-II antibody. In these experiments, we observed Ann-II expression localized to the plasma membrane and neurites. Cells stained with anti-Ann-VI (Fig. 1D) , on the other hand, showed no immunofluorescent staining.
Ann-II Steady State Message Levels Are Rapidly Up-regulated in NGF-treated PC-12 Cells but Not in HUVEC or PC-12 Cells Lacking Functional p21
ras -To determine whether the increased expression of Ann-II protein in NGF-treated PC-12 cells reflected an increase in steady state mRNA levels, we performed Northern blot analysis of total RNA extracted from PC-12 cells treated with or without 50 ng/ml NGF for 5 days. In response to NGF, Ann-II but not Ann-I message levels were elevated ( Fig. 2A) , suggesting that the up-regulatory effect of NGF was specific for Ann-II and not for other members of the annexin family. The Ann-II response to NGF was dose-dependent (Fig. 2B) and displayed a time course (Fig. 2C ) that began within 3 h after the addition of the neurotrophin. Maximal induction was attained by 12 h, whereupon it remained relatively steady for 5 days. The up-regulatory effect of NGF upon Ann-II was observed only in wild type PC-12 cells (Fig. 2D) . Although HUVEC possessed higher basal levels of Ann-II than PC-12 cells, they did not exhibit increased Ann-II expression in response to NGF. Likewise, we observed no increase in Ann-II message in NGF-treated N17 cells, a PC-12 cell line that expresses a dominant negative mutant form of p21 ras and is unable to grow neurites in response to NGF treatment (32) . These data suggested that p21
ras -dependent signal transduction may be responsible for the NGF-induced up-regulation of Ann-II in PC-12 cells. We also observed no significant increase in Ann-II message levels in response to 50 ng/ml EGF (Fig. 2E) , suggesting that the up-regulation of Ann-II is an NGF-specific phenomenon and not a general response of PC-12 cells to growth factor stimuli.
Effect of NGF upon Ann-II Message Stability in PC-12
Cells-In eukaryotic cells, gene expression is controlled by mechanisms that influence both transcriptional and post-transcriptional events. For many inducible genes, an increase in steady state message levels may result from increased transcription and/or a reduction in mRNA decay rates. To determine which mechanism is responsible for the NGF-induced regulation of Ann-II, we studied the stability of Ann-II mRNA in the presence of actinomycin D, an inhibitor of eukaryotic transcription (39) as described under "Experimental Procedures." We observed no significant difference in the half-disappearance time of Ann II message between untreated (14.5 Ϯ 3.2 h; S.E., n ϭ 3), EGF-treated (14.6 Ϯ 1.3 h; S.E., n ϭ 3), or NGF-treated (16.3 Ϯ 0.4 h; S.E., n ϭ 3) PC-12 cells incubated in the presence of actinomycin D. The results of the message stability assays were confirmed by a nuclear run-on assay (Fig.  3) in which NGF conferred a 5-fold increase in the rate of transcription of Ann-II but not 28 S heteronuclear RNA levels. Together, these data suggest that the NGF-induced accumulation of Ann-II message reflects an increase in de novo transcription rather than an increase in message stability.
Immunologic Blockade with Monoclonal or Polyclonal Antibodies Directed against Ann-II Inhibits NGF-induced Neurite
Outgrowth-To study the role of Ann-II during NGF-induced PC-12 cell differentiation, we employed an immunologic blockade assay using both polyclonal and monoclonal antibodies directed against Ann-II. In PC-12 cultures propagated on a two-dimensional collagen matrix (Fig. 4A ), 52.5 Ϯ 2.4% (S.E., n ϭ 6) of the NGF-treated cells possessed neurites that were at least 2 times the cell body in length compared with 0.4 Ϯ 0.3% (S.E., n ϭ 6) for the untreated control. We observed a 66% reduction in the number of neurite-bearing cells in cultures treated with NGF in the presence of polyclonal anti-Ann-II IgG. Preimmune rabbit IgG, on the other hand, resulted in only a 24% reduction in neurite outgrowth. Similar results were obtained with PC-12 cells treated with NGF in the presence of monoclonal antibodies. Monoclonal anti-Ann-II antibody brought about a 63% reduction in the number of cells with neurites, whereas anti-Ann-I IgG reduced the number of neurite sprouting cells by only 21%. Similarly, in PC-12 cell cultures grown within a three-dimensional Matrigel matrix (Fig.  4, B-E) , 60.7 Ϯ 2.0% (S.E., n ϭ 3) of the NGF-treated cells possessed neurites that met our criterion. Treatment with the monoclonal anti-Ann-II antibody resulted in a 53% decrease in neurite counts, whereas anti-Ann-VI brought about an 8% decrease. These data suggest that the immunologic blockade of Ann-II specifically impairs NGF-induced neuritogenesis in both two-and three-dimensional matrices.
PC-12 Cells Stably Transfected with an Antisense Ann-II Expression Vector Display a Reduced Ability to Develop Neurites during NGF-induced Differentiation-
The role of Ann-II in neurite outgrowth was further examined in PC-12 cells that had been stably transfected with a zinc-inducible expression construct containing Ann-II cDNA in either the antisense or the sense orientation ( lysates revealed an 86% reduction in Ann-II protein levels in antisense-transfected cells compared with the sense-transfected control. In the absence of NGF, essentially no neurite formation was observed in any of the transfected PC-12 cell lines. After 2, 3, 4, and 6 days of continuous NGF treatment, 11.4 Ϯ 2.3% (S.E., n ϭ 4), 13.2 Ϯ 2.4% (S.E., n ϭ 5), 17.2 Ϯ 2.3% (S.E., n ϭ 5), and 40 Ϯ 3.2% (S.E., n ϭ 4) of the nontransfected and 9.4 Ϯ 2.3% (S.E., n ϭ 4), 9.7 Ϯ 2.1% (S.E., n ϭ 5), 8.1 Ϯ 2.5% (S.E., n ϭ 5), and 32 Ϯ 2.2% (S.E., n ϭ 4) of the stable Ann-II sense transfected PC-12 cells possessed neurites at least two cell bodies in length. In contrast, the percentage of cells with neurites in a PC-12 cell line stably transfected with an Ann-II antisense construct was only 2.5 Ϯ 0.5% (S.E., n ϭ 4), 2.4 Ϯ 0.5% (S.E., n ϭ 5), 2.8 Ϯ 1.1% (S.E., n ϭ 5), and 4.3 Ϯ 1.3% (S.E., n ϭ 4) during the same intervals. These results suggested that the expression of Ann-II antisense polynucleotide inhibits neurite formation and that Ann-II expression is required for NGF-induced neuritogenesis.
NGF-induced Neurite Outgrowth in PC-12 Cells Is Blocked by ⑀ACA, Antibodies against t-PA and u-PA, and ␣ 2 -Plasmin
Inhibitor-To study the role of plasmin generation during neuritogenesis, we treated PC-12 cells grown on a collagen matrix with NGF in the presence of ⑀ACA, a lysine analog that inhibits Plg activation (40) and disrupts the "kringle"-mediated binding of Plg to Ann-II (18) . In the presence of increasing concentrations of ⑀ACA, we observed a dose-dependent reduction in the percentage of cells bearing neurites (Fig. 6A) . Lactate dehydrogenase assays and trypan blue exclusion revealed no evidence of cytotoxicity as a result of the ⑀ACA treatment. Cells treated with NGF plus 0.1, 1, and 10 mM ⑀ACA displayed 58, 68, and 82% fewer cells with neurites, respectively, than those cells treated with NGF alone. By contrast, co-treatment with 10 mM Control cells were treated with NGF plus 10 mM NaCl. For each group, the percentage of cells bearing neurites at least two cell bodies in length was determined as described under "Experimental Procedures." Data are shown as mean values Ϯ S.E. (n ϭ 4). *, p Ͻ 0.0002-0.0016 compared with control; #, p Ͻ 0.27 compared with control. B, effect of inhibitory antibodies against the Plg activators. PC-12 cells grown within a three-dimensional matrix were treated as described under "Experimental Procedures" for 3 days either with 50 ng/ml NGF or with NGF in the presence of either 10 g/ml monoclonal anti-t-PA, 10 g/ml anti-u-PA, 10 g/ml both anti-t-PA and anti-u-PA together, or 10 g/ml anti-Ann-VI. For each group, the percentage of cells bearing neurites at least two cell bodies in length was determined as described under NaCl resulted in only a 14% reduction in neurite counts. This observation eliminated the possibility that the effects of ⑀ACA upon neurite growth were due to osmotic changes. These data suggest that Plg binding to a cell surface receptor such as Ann-II is required for the outgrowth of neurites in NGF-treated PC-12 cells. In addition, they also provide further evidence that plasmin generation may be involved in neuritogenesis.
To further study the role of plasmin generation during NGFinduced neurite outgrowth, we treated PC-12 cells grown within a three-dimensional Matrigel matrix with antibodies directed against t-PA and u-PA (Fig. 6B) . We observed neurites at least 2 times the cell body in length in 58.8 Ϯ 5.8% (S.E., n ϭ 5) of the NGF-treated cells. Co-treatment with antibodies against t-PA, u-PA, or both Plg activators resulted in 35, 46, and 58% fewer neurites, respectively. These data suggested that the activation of Plg by t-PA and/or u-PA may be required for neuritogenesis to proceed. These results were supported by additional studies in which we observed a 67% reduction in neurite counts in PC-12 cells treated with 100 nM ␣ 2 -plasmin inhibitor (Fig. 6C) . These data suggest that plasmin generated by differentiating PC-12 cells in response to NGF is essential for the growth of neurites.
NGF-induced Plasmin Generation by PC-12 Cells Is Blocked by a Polyclonal Antibody against an Ann-II Tail
Peptide-To determine whether plasmin generation in NGF-treated PC-12 cells is mediated by Ann-II, we performed fluorogenic plasmin generation assays (Fig. 7) . PC-12 cells treated with 50 ng/ml NGF for 5 days displayed a 2.1 Ϯ 0.2-fold (S.E., n ϭ 7) increase in plasmin generation compared with an untreated control. NGF-treated cells preincubated with a polyclonal antibody directed against a peptide in the tail domain of Ann-II showed a 1.2 Ϯ 0.2-fold (S.E., n ϭ 4) increase in plasmin activity, while the addition of preimmune IgG had no effect upon plasmin generation (2.1 Ϯ 0.2-fold (S.E., n ϭ 3)). The antibodies had no effect upon plasmin generation in the absence of PC-12 cells. In addition, we detected no plasmin generation in the absence of PC-12 cells or plasminogen. Interestingly, Ann-II-mediated plasmin generation in PC-12 cells was partially blocked in a dose-dependent manner by 100 -300 nM tenascin-C, a hexameric matrix glycoprotein that can bind to extracellular Ann-II (20) (data not shown). These data indicate that increased plasmin generation by NGF-treated PC-12 cells is Ann-II-mediated and possibly regulated by tenascin-C. Furthermore, these data suggest that the functional significance of up-regulated cell surface Ann-II in differentiating PC-12 cells may be related to Ann-II's potential role as a co-receptor for t-PA and Plg that enhances plasminogen activation on the cell surface.
DISCUSSION
In the present study, we observed the up-regulation of Ann-II expression in PC-12 cells treated with NGF. Western blot analysis of cell surface eluates and whole cell lysates (Fig.  1, A and B) from NGF-treated cells revealed increased amounts of Ann-II antigen, while indirect immunofluorescence (Fig. 1, C  and D) showed strong Ann-II expression localized on the cell surface. Northern blot analysis revealed a 3-9-fold increase in steady state mRNA levels for Ann-II but not Ann-I (Fig. 2A) . The induction of Ann-II message by NGF was dose-related, attained a steady state level by 12 h, and was ras-dependent (Fig. 2, B-D) . This response was specific for NGF and was not observed with equivalent doses of EGF (Fig. 2E) . Nuclear run-on analyses revealed a 5-fold increase in the rate of Ann-II mRNA transcription in response to NGF (Fig. 3) . However, NGF did not exert a significant effect upon Ann-II mRNA stability. These data suggest that the transcriptional up-regulation of Ann-II is a component of the differentiation response to NGF by PC-12 cells.
The functional significance of the NGF-induced up-regulation of Ann-II was revealed in neurite outgrowth assays performed on both two-and three-dimensional matrices. NGFinduced neuritogenesis was blocked 53-66% by polyclonal and monoclonal anti-Ann-II IgG but not by preimmune rabbit IgG, anti-Ann-I, or anti-Ann-VI (Fig. 4) . The overexpression of antisense but not sense Ann-II message in stably transfected PC-12 cells also resulted in decreased neurite outgrowth (Fig.  5) . Further studies revealed a dose-related inhibition of NGF- FIG. 7 . Effect of Ann-II tail peptide antibody upon NGF-induced plasmin generation. PC-12 cells grown upon a collagen matrix were treated for 5 days without or with 50 ng/ml NGF and used in a fluorogenic plasmin generation assay as described under "Experimental Procedures." The -fold increase in plasmin generation was calculated by normalizing the initial rates of plasmin generation for PC-12 cells treated with 20 g/ml polyclonal Ann-II immune IgG, 20 g/ml preimmune rabbit IgG, NGF, NGF plus immune IgG against Ann-II, or NGF plus preimmune rabbit IgG versus the untreated control, which was assigned a value of 1.0. Data are shown as mean values Ϯ S.E. (n ϭ 7 for no antibody; n ϭ 4 for immune IgG; or n ϭ 3 for preimmune rabbit IgG).
induced neuritogenesis by ⑀ACA (Fig. 6A) and ␣ 2 -plasmin inhibitor (Fig. 6C) . Because neutralizing antibodies directed against t-PA and u-PA inhibited neurite outgrowth by 35 and 46%, respectively (Fig. 6B ), it appears that both plasminogen activators may play a role in this process. These data suggest that both Ann-II expression and plasmin generation are essential for NGF-induced neuritogenesis in PC-12 cells.
Neuritogenesis, a well established indicator of NGF-induced differentiation in PC-12 cells (5), is a complex process that is thought to require matrix remodeling through the highly regulated action of one or more proteases. Neuronal proteases have been reported to be localized to distal processes and neurite growth cones (7, 41, 42) , and protease inhibitors have been shown to inhibit neurite outgrowth in three-dimensional matrices (43, 44) . The pattern of Ann-II expression within the developing nervous system (24) displays striking spatial and temporal similarities with that of t-PA expression (6) . Both proteins are expressed by cells lining the floor plate of the spinal cord during a stage of embryogenesis in which commissural axons penetrate the floor plate and make a 90°turn to proceed along the spinal cord axis (6) . It seems likely that Ann-II and t-PA may play a direct role in this process of axonal decussation, given their overlapping yet tissue-specific pattern of expression and the ability of Ann-II to mediate t-PA-dependent plasmin generation.
Ann-II interacts with both t-PA and its primary substrate, plasminogen, via independent binding sites (19) . Plasminogen and t-PA are both produced by PC-12 cells, and both bind to the cell surface in a saturable manner (13) . Interestingly, the kinetics of t-PA binding to its high affinity PC-12 cell receptor (K d ϭ 23 nM, B max ϭ 340,000 sites/cell) (12) closely approximates that of the t-PA-Ann-II interaction (K d ϭ 18 nM, B max ϭ 815,000 sites/cell) that we have observed on the surface of endothelial cells (45) . We have previously demonstrated that the binding of t-PA to Ann-II on endothelial cells protects it from its physiologic inhibitor, PAI-1, while preserving its ability to activate Plg (45) . By analogy, t-PA bound to Ann-II on the PC-12 cell would also be expected to result in enhanced plasminogen activation. Indeed, fluorogenic plasmin generation assays performed on NGF-treated PC-12 cells (Fig. 7) revealed a 2-fold increase in plasmin generation, which could be blocked by a polyclonal antibody directed against the tail region of Ann-II. These data suggest that the plasmin generation required for neuritogenesis during the NGF-induced differentiation of PC-12 cells may be Ann-II-mediated. The partial inhibition of Ann-II-mediated plasmin generation by tenascin-C most likely occurs via steric blockade of the t-PA or plasminogen binding sites on Ann-II. Further studies are required to determine the precise role played by tenascin-C during neuronal differentiation and its effect upon Ann-II-mediated plasmin generation.
Sustained movement of a neurite through the extracellular matrix requires interactions between the growth cone and its surroundings that must continually alternate between adhesion and detachment (44, 46) . Neurite-bound plasminogen activators may facilitate this process via several mechanisms. They may stabilize and anchor the growing neurite by forming transient interactions with cell surface-bound or matrix-bound plasminogen activator inhibitors (13, 47) . Such a mechanism might explain the surprising stimulatory effect of plasminogen activator inhibition upon neurite outgrowth in certain systems (43) . Alternatively, the t-PA-or u-PA-catalyzed generation of plasmin on the neurite surface may directly degrade extracellular matrix proteins and/or release cell-matrix adhesions (9) . It has also been suggested that plasmin may catalyze the degradation of laminin, a major component of the neuronal extracellular matrix, although other plasmin-activated proteases may also participate in the remodeling of a laminin-rich matrix (48) . Finally, neuronal plasminogen activators may also stimulate neuritogenesis by releasing matrix-bound growth factors or by activating other proteases such as the matrix metalloproteinases (MMPs) (47) .
The vertebrate MMP family consists of at least 20 Zn 2ϩ -dependent proteases that are capable of degrading various extracellular matrix components as well as activating other MMPs (49) . Most MMPs are secreted as proenzymes and are activated in a stepwise manner under certain pathological and physiological conditions requiring matrix remodeling (50) . In cultured rat sympathetic neurons, a metalloproteinase released from the neurite growth cone was essential for neurite penetration into a three-dimensional collagen matrix (41) . NGF-treated embryonic chick DRG cultures also expressed a metalloproteinase whose activity enhanced neurite penetration within a reconstituted matrix (44) . Plasmin has been suggested to play a role in the initial activation step of MMP-1, -3, -7, and -10 (50). Like Ann-II, MMP-3 is strongly up-regulated in PC-12 cells undergoing NGF-induced neuritogenesis (42, 51) , and, like t-PA and Ann-II, it is also expressed by the floor plate cells of the developing spinal cord (42) . Thus, it seems quite plausible that the plasmin generated by differentiating neuronal cells and tissues may modify the neurite-extracellular matrix interface through the activation of MMP-3 or a closely related metalloproteinase.
In this study, we demonstrate for the first time that NGFinduced neuritogenesis in PC-12 cells requires the expression of functional Ann-II and the Ann-II-mediated generation of plasmin. In the past, plasmin has been considered an intravascular protease whose only substrate is fibrin-rich thrombi. The work described here is part of a growing body of evidence suggesting that plasmin may also function in an extravascular environment by cleaving nonfibrin substrates. These data suggest a model of regulated Ann-II-mediated plasminogen activation on the cell surface that results in the direct or indirect degradation of the extracellular matrix. In addition to illustrating the means by which neuronal cells may migrate and extend axons, this model may provide insights into other processes that are dependent upon matrix remodeling such as tumor cell metastasis, cell migration, angiogenesis, and wound healing.
